| Identification | More | [Name]
6-PIPERAZINONICOTINONITRILE | [CAS]
149554-29-0 | [Synonyms]
2-(1-PIPERAZINO)PYRIDINE-5-CARBONITRILE
2-(PIPERAZIN-1-YL)-5-PYRIDINECARBONITRILE
6-PIERAZINONICOTINONITRILE
6-PIPERAZINONICOTINONITRILE
6-(PIPERAZINO)PYRIDINE-3-CARBONITRILE
BUTTPARK 37\12-47
6-Piperazinonicotinonitrile, tech
3-Pyridinecarbonitrile,6-(1-piperazinyl)-(9CI)
2-(PIPERAZIN-1-YL)-5-PYRIDINECARBONITRILE, 6-PIPERAZINONICOTINONITRILE >98%
2-(PIPERAZIN-1-YL)-5-PYRIDINECARBONITRILE, 6-PIPERAZINONICOTINONITRILE | [Molecular Formula]
C10H12N4 | [MDL Number]
MFCD00833024 | [Molecular Weight]
188.23 | [MOL File]
149554-29-0.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [RIDADR ]
3439 | [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [HS Code ]
29339900 |
| Hazard Information | Back Directory | [Chemical Properties]
Colorless to light yellow powder or chunks | [Uses]
6-Piperazinonicotinonitrile acts as a reagent in the synthesis and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for treatment of type 2 Diabetes. |
|
|